Cannabinoids are stepping into the ring to help fight cancer. SōRSE Technology Technology has acquired cancer drug development company Pascal Biosciences and its cannabinoid programs in a deal that values the joint companies at $60 million. SōRSE Technology CEO Howard Lee joined Cheddar to discuss.